Form 4: InfuSystem Holdings Executive VP Addam Chupa Reports Stock Transactions
SEC Form 4
Executive VP and CIO of InfuSystem Holdings, Addam Chupa, reports acquisition and disposal of company stock and derivative securities.
Summary
- Addam Chupa, Executive VP and CIO of InfuSystem Holdings, filed a Form 4 detailing changes in beneficial ownership.
- On May 17, 2024, Chupa acquired 2,850 shares of common stock upon vesting of performance-based restricted stock units granted on May 17, 2022.
- Also on May 17, 2024, 987 shares were withheld for tax liability related to the vesting of these restricted stock units at a price of $6.44.
- Chupa also acquired 53,528 stock options (right to buy) on May 17, 2024.
- On May 21, 2024, Chupa purchased 1,000 shares of common stock at a weighted average price of $6.67.
- Chupa now directly owns 24,774 shares of common stock.
- Chupa also now owns 11,830 restricted stock units and 53,528 stock options.
- The stock options vest in four equal annual installments beginning May 17, 2025.
Sentiment
Score: 6
Explanation: Neutral sentiment as the filing primarily reflects routine stock transactions related to executive compensation. The acquisitions suggest confidence, but the tax withholding is a neutral event.
Positives
- The vesting of restricted stock units and subsequent purchase of shares by an executive could be seen as a positive signal, indicating confidence in the company's future performance.
- The acquisition of 53,528 stock options shows a long-term commitment to the company's success.
Negatives
- The withholding of shares for tax liability, while standard, reduces the overall increase in beneficial ownership.
Risks
- Executive stock transactions are subject to market fluctuations and company performance.
- Changes in executive compensation structures could impact future transactions.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are often monitored by investors for insights into management's confidence in the company's prospects. Form 4 filings are a standard part of regulatory compliance.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock units, are common across the healthcare and technology industries.
- Companies like Medtronic and Stryker also utilize similar equity-based compensation to align executive interests with shareholder value.
- The vesting schedules and exercise prices are generally in line with industry norms for companies of similar size and market capitalization.
Stakeholder Impact
- The transactions could influence investor perception of management's confidence in the company.
- Employees participating in the Employee Stock Purchase Plan are also stakeholders affected by stock price fluctuations.
Key Dates
| Date | Description |
|---|---|
| 05/17/2022 | Date performance-based restricted stock units were granted. |
| 05/17/2024 | Date of restricted stock units vesting, stock option acquisition, and tax withholding. |
| 05/21/2024 | Date of common stock purchase. |
| 05/17/2025 | Start date for annual vesting installments of stock options. |
| 05/17/2027 | Expiration date of restricted stock units. |
| 05/17/2034 | Expiration date of stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.